HAIER BIOMEDICAL(SH:688139) Huan Qiu Wang·2025-11-08 06:17Core Viewpoint - Haier Biomedical has achieved a significant breakthrough in ultra-high-speed centrifuge technology, marking a transition from reliance on imports to self-sufficiency in high-end life science instruments in China [1][3]. Group 1: Product Development - The newly launched ultra-high-speed centrifuge can reach a maximum speed exceeding 100,000 RPM, filling a gap in the domestic market for ultra-high-speed centrifuge equipment [1][3]. - The centrifuge's performance in terms of speed stability, data security, and rotor compatibility has reached the advanced level of international counterparts [3][4]. Group 2: Market Context - The demand for ultra-high-speed centrifuges is increasing due to advancements in cell therapy, vaccine development, and pharmaceutical processes, which require higher efficiency than conventional centrifuges can provide [3]. - As of 2025, leading international brands are projected to hold approximately 62% of the centrifuge market in China, highlighting the importance of domestic technological self-reliance [3]. Group 3: Application and Impact - The ultra-high-speed centrifuge is designed to enhance particle separation and purity control, which is crucial for the isolation and purification of microscopic samples such as viral particles and natural proteins [4]. - The device has broad application potential across various fields, including materials science and cell engineering, providing significant support for safe and effective sample preparation [4].